|Bid||6.96 x 0|
|Ask||6.98 x 0|
|Day's Range||6.80 - 7.49|
|52 Week Range||6.28 - 11.50|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 15, 2019 - Jul 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.90|
TORONTO and RIONEGRO, Colombia , May 24, 2019 /CNW/ - PharmaCielo Ltd. (" PharmaCielo " or the " Company ") ( TSXV:PCLO ), the Canadian parent of Colombia's premier cultivator and ...
Colombia's substantial comparative advantage for cannabis cultivation makes now the time to buy PharmaCielo Ltd. (TSXV:PCLO).
Cannabis Updates: Price Action, Ratings, and MoreCannabis spaceThe cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively, while the
Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.
Predominantly, most countries which have adopted cannabis legislation have legalized the plant specifically for medical purposes. Countries such as Argentina, Chile, Colombia, and Brazil have all legalized medical cannabis, while some have also decriminalized cannabis, allowing for moderate personal consumption. In combination, all of these factors are further accelerating the Latin American cannabis industry by inviting new business opportunities.
Oil processing facility is on track for commercial operation and GMP certification during Q3-2019, enabling large-scale production and sale of refined cannabis oil. Currently, 10 hectares are under active cultivation, expanding to 20 hectares (~2.15 million square feet) by year-end 2019, backed by 20 proprietary registered strains and 186 strains in the Company's germplasm bank. PharmaCielo's common shares began trading on the TSX Venture Exchange ("TSXV" or "TSX Venture") under the ticker PCLO on January 18, 2019.
Additionally, a survey conducted by Colorado Tourism reported that 12 million, or approximately 15%, of those travelers participated in marijuana-related activities. Around the world, even though the cannabis industry remains in its infancy stage, more and more countries continue to legalize the plant. Thusly, the consumer base is projected to grow, propelling the overall market even further, as according to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.
Every investor in PharmaCielo Ltd. (CVE:PCLO) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ow...
In their report, "The Road Map to $57 Billion Worldwide Market," analysts note that the South American market for example could grow from $125 million in 2018 to $776 million by 2027. The Yield Growth Corporation (BOSS)(BOSQF) just entered into an agreement with Pontier Services to set up Urban Juve hemp beauty products for e-commerce sales in WeChat, in addition to launching a marketing campaign with AI-enabled pop-up kiosks to rotate through six major locations in Hong Kong beginning in June 2019. Such a move will establish Urban Juve as the first Canadian brand to launch Pop Square AI-enabled pop-up kiosks in China.
TORONTO and RIONEGRO, Colombia, April 9, 2019 /CNW/ - David Attard, Chief Executive Officer of PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the appointment of the Company's extended Medical and Scientific Advisory Board (MSAB).
HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics. In their report, ...
TORONTO and RIONEGRO, COLOMBIA, March 29, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received from the national cultivar registry approval for the listing of a further 10 strains, each of which has a prominent tetrahydrocannabinol (THC) profile. The additional registration of the new strains to the national cultivar registry, including a unique 1:1 THC to CBD ratio strain, doubles the number of approved strains PharmaCielo holds in the registry, making it the largest holder of approved strains in Colombia.
PharmaCielo Ltd. (OTCMKTS:PHCEF), which owns Colombia's based medicinal-grade cannabis oil cultivator and producer PharmaCielo Colombia Holdings S.A.S., said that they have received the ISO 9001:2015 certification for its cultivation and extraction operations. ISO 9001 is the international standard that specifies requirements for a quality management system. Organizations use the standard to show their ability to […]The post PharmaCielo Becomes 1st Colombia's Cannabis Producer to Earn ISO Certification appeared first on Market Exclusive.
Canopy Growth (TSX: WEED) (NYSE: CGC) and OG DNA Genetics have signed an new partnership agreement. Under the terms of the agreement, the companies will work together to expand into global markets, including Europe. GB Sciences (OTCQB: GBLX) launched a Canada-based cannabinoid medicine company GBS Global Biopharma. The company will develop cannabinoid medicines for medical […]The post Cannabis Stock News Daily Roundup March 19 appeared first on Market Exclusive.
TORONTO and RIONEGRO, Colombia, March 19, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the Company has received the ISO 9001:2015 certification for its cultivation and extraction operations.
NEW YORK, March 5, 2019 /CNW/ -- The cannabis industry has recently been finding backers in major global investment banking firms such as Piper Jaffray, RBC Capital Markets, and Cowen. Piper Jaffray analyst Michael Lavery noted that there are more than 25 countries that have legalized marijuana of some form. According to data compiled by MarketsandMarkets, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023.
NEW YORK, Feb. 28, 2019 /CNW/ --The Latin America region has become highly sought after for cannabis businesses due to the opportunities it represents. Around the globe, many cannabis businesses have moved to establish operations in LATAM because of the area's low cultivation costs and fertile farming lands, as countries including Peru, Chile, Argentina, and Colombia have all passed favourable medical cannabis laws. Meanwhile, Uruguay has entirely legalized cannabis for both recreational and medical use.
NEW YORK, Feb. 25, 2019 /CNW/ -- Following Canada's legalization of cannabis, the North American cannabis industry is positioned to account for the majority of the global marketplace. Canada legalized recreational cannabis nationwide in October, making it the first G-7 country to do so. Now, Mexico's President-elect party is moving to legalize cannabis as well.
NEW YORK, Feb. 19, 2019 /CNW/ -- The expansion of the cannabis industry has led companies involved in the marketplace to expand internationally as larger players are extending their operations into other regions such as Europe and Latin America. According to Verified Market Intelligence, the global marijuana market was valued at USD 42.20 Billion in 2017 and is expected to reach USD 466.81 Billion by 2025. The market is primarily being accelerated by the growing adoption of medical cannabis for the treatment of chronic diseases.
NEW YORK, Feb. 14, 2019 The cannabis industry is an attractive investment opportunity for entrepreneurs, however, entering into the market poses a challenge for many. In order to mitigate their losses, many began to establish operations in Latin America, specifically in countries such as Argentina, Brazil, Chile, Colombia, and Peru. According to data compiled by BDS Analytics in partnership with Arcview Research, the South American legal cannabis spending is expected to grow from USD 125 Million in 2018 to USD 776 Million by 2026.
HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. "Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment," noted The Globe and Mail. Blueberries Medical Corp. (BBM), for example, just entered into a letter of intent for a joint venture with Harmony and Life S.A.S., operating as El Manantial medical centers.
TORONTO and RIONEGRO, Colombia, Feb. 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received approval for the listing of 10 proprietary and unique tetrahydrocannabinol (THC) and cannabidiol (CBD) strains with the national cultivar registry. The Company can now proceed to commercial registration, production and sale of these strains within Colombia as well as for export to global markets.